| Item Type | Name |
|
Academic Article
|
Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
|
|
Academic Article
|
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation.
|
|
Academic Article
|
Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997-8.
|
|
Academic Article
|
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus.
|
|
Academic Article
|
Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.
|
|
Academic Article
|
Influenza A virus outbreak in a neonatal intensive care unit.
|
|
Academic Article
|
Why no effect of maternal respiratory syncytial virus-neutralizing antibody?
|
|
Academic Article
|
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women.
|
|
Academic Article
|
Safety of influenza vaccination during pregnancy.
|
|
Concept
|
Infant, Newborn, Diseases
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Respiratory Distress Syndrome, Newborn
|
|
Academic Article
|
Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program.
|
|
Academic Article
|
Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments.
|
|
Academic Article
|
Research on vaccines during pregnancy: protocol design and assessment of safety.
|
|
Academic Article
|
Maternal immunization: an update for pediatricians.
|
|
Academic Article
|
Clinical characteristics and outcomes of neonatal pertussis: a comparative study.
|
|
Academic Article
|
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
|
|
Academic Article
|
Central nervous system manifestations in pediatric patients with influenza A H1N1 infection during the 2009 pandemic.
|
|
Academic Article
|
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.
|
|
Academic Article
|
Clinical predictors of disease severity during the 2009-2010 A(HIN1) influenza virus pandemic in a paediatric population.
|
|
Academic Article
|
Clinically silent infection in a premature infant.
|
|
Academic Article
|
Vaccines in pregnancy.
|
|
Academic Article
|
A step ahead. Infant protection through maternal immunization.
|
|
Academic Article
|
Palivizumab Prophylaxis for Healthy Preterm Infants: More Data Supporting American Academy of Pediatrics Guidelines.
|
|
Academic Article
|
Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
|
|
Academic Article
|
Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
|
|
Academic Article
|
Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
|
|
Academic Article
|
Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
|
|
Academic Article
|
Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
|
|
Academic Article
|
Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
|
|
Academic Article
|
Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
|
|
Academic Article
|
Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.
|
|
Academic Article
|
Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
|
|
Academic Article
|
Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
|
|
Academic Article
|
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States.
|
|
Academic Article
|
Recommended Childhood and Adolescent Immunization Schedules: United States, 2018.
|
|
Academic Article
|
Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
|
|
Academic Article
|
A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.
|
|
Academic Article
|
Infectious and Autoimmune Causes of Encephalitis in Children.
|
|
Academic Article
|
Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.
|
|
Academic Article
|
Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
|
|
Academic Article
|
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.
|
|
Academic Article
|
Vaccine implementation factors affecting maternal tetanus immunization in low- and middle-income countries: Results of the Maternal Immunization and Antenatal Care Situational Analysis (MIACSA) project.
|
|
Academic Article
|
Antenatal care service delivery and factors affecting effective tetanus vaccine coverage in low- and middle-income countries: Results of the Maternal Immunisation and Antenatal Care Situational analysis (MIACSA) project.
|
|
Academic Article
|
Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening "Allies in Maternal and Newborn Care"; May 3-4, 2018.
|
|
Academic Article
|
Neonatal seizures: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
|
|
Academic Article
|
Maternal Immunization.
|
|
Academic Article
|
The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case series.
|
|
Academic Article
|
Caregiver rating of early childhood development: Reliability and validity of the ASQ-3 in rural Guatemala.
|
|
Academic Article
|
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.
|
|
Academic Article
|
Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling.
|
|
Academic Article
|
Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol.
|
|
Academic Article
|
Can We Protect Pregnant Women and Young Infants From COVID-19 Through Maternal Immunization?
|
|
Academic Article
|
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004).
|
|
Academic Article
|
A prospective cohort study of head circumference and its association with neurodevelopmental outcomes in infants and young children in rural Guatemala.
|
|
Academic Article
|
Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
|
|
Academic Article
|
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
|
|
Academic Article
|
Anthropometric proxies for child neurodevelopment in low-resource settings: length- or height-for-age, head circumference or both?
|
|
Academic Article
|
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database.
|
|
Academic Article
|
Commentary: Perinatal Coronavirus Disease 2019 and Maternal Vaccination: What More Do We Need to Know?
|
|
Academic Article
|
The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next Generation.
|
|
Academic Article
|
Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of Age.
|
|
Academic Article
|
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020-February 2021.
|
|
Academic Article
|
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.
|
|
Academic Article
|
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
|